Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 15

1.

Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.

Daniel AR, Faivre EJ, Lange CA.

Mol Endocrinol. 2007 Dec;21(12):2890-906. Epub 2007 Aug 23.

PMID:
17717077
2.

Tracking progesterone receptor-mediated actions in breast cancer.

Knutson TP, Lange CA.

Pharmacol Ther. 2014 Apr;142(1):114-25. doi: 10.1016/j.pharmthera.2013.11.010. Epub 2013 Nov 26. Review.

3.
4.

Signaling inputs to progesterone receptor gene regulation and promoter selectivity.

Daniel AR, Knutson TP, Lange CA.

Mol Cell Endocrinol. 2009 Sep 24;308(1-2):47-52. doi: 10.1016/j.mce.2009.01.004. Epub 2009 Jan 20. Review.

5.

Progesterone receptor action: translating studies in breast cancer models to clinical insights.

Lange CA, Sartorius CA, Abdel-Hafiz H, Spillman MA, Horwitz KB, Jacobsen BM.

Adv Exp Med Biol. 2008;630:94-111. Review.

PMID:
18637487
6.

Role of phosphorylation in progesterone receptor signaling and specificity.

Hagan CR, Daniel AR, Dressing GE, Lange CA.

Mol Cell Endocrinol. 2012 Jun 24;357(1-2):43-9. doi: 10.1016/j.mce.2011.09.017. Epub 2011 Sep 16. Review.

7.
8.

Integration of progesterone receptor action with rapid signaling events in breast cancer models.

Lange CA.

J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):203-12. Epub 2007 Sep 14. Review.

9.

Post-translational modifications of the progesterone receptors.

Abdel-Hafiz HA, Horwitz KB.

J Steroid Biochem Mol Biol. 2014 Mar;140:80-9. doi: 10.1016/j.jsbmb.2013.12.008. Epub 2013 Dec 12. Review.

10.

More help than hindrance: nucleosomes aid transcriptional regulation.

Ballaré C, Zaurin R, Vicent GP, Beato M.

Nucleus. 2013 May-Jun;4(3):189-94. doi: 10.4161/nucl.25108. Epub 2013 May 28. Review.

11.

[Aspects of progesterone receptor (PR) activity regulation - impact on breast cancer progression].

Piasecka D, Składanowski AC, Kordek R, Romańska HM, Sądej R.

Postepy Biochem. 2015;61(2):198-206. Review. Polish.

PMID:
26689013
12.

Targeting progesterone receptors in breast cancer.

Giulianelli S, Molinolo A, Lanari C.

Vitam Horm. 2013;93:161-84. doi: 10.1016/B978-0-12-416673-8.00009-5. Review.

PMID:
23810006
13.

Progesterone action in breast, uterine, and ovarian cancers.

Diep CH, Daniel AR, Mauro LJ, Knutson TP, Lange CA.

J Mol Endocrinol. 2015 Apr;54(2):R31-53. doi: 10.1530/JME-14-0252. Epub 2015 Jan 13. Review.

14.

Recent advances in structure of progestins and their binding to progesterone receptors.

Cabeza M, Heuze Y, Sánchez A, Garrido M, Bratoeff E.

J Enzyme Inhib Med Chem. 2015 Feb;30(1):152-9. doi: 10.3109/14756366.2014.895719. Epub 2014 Mar 25. Review.

PMID:
24666307
15.

Progestin receptor subtypes in the brain: the known and the unknown.

Mani S.

Endocrinology. 2008 Jun;149(6):2750-6. doi: 10.1210/en.2008-0097. Epub 2008 Feb 28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk